Solute carrier transporters: emerging central players in tumour immunotherapy

Trends Cell Biol. 2022 Mar;32(3):186-201. doi: 10.1016/j.tcb.2021.08.002. Epub 2021 Sep 9.

Abstract

Solute carrier transporters (SLCs) mediate nutrient and metabolite cellular homeostasis. Immune cells depend on SLCs to induce rapid and robust metabolic reprogramming, thereby controlling diverse immunological responses. Recent studies hint toward an important role of SLCs in immunity. Here, we review the emerging roles of SLCs in immunotherapy via modifying the metabolism and effector functions of immune cells. We focus on the roles of three major nutrient (glucose, amino acid, and lipid)-related transporters in immunity of representative cells [T cells, dendritic cells (DCs), natural killer (NK) cells, and macrophages) in innate and adaptive immunity. Other SLCs, such as ion transporters are also briefly discussed. Finally, we propose some potential strategies for targeting SLCs to augment tumour immunotherapy.

Keywords: immunocyte; metabolic reprogramming; nutrient and metabolite; solute carrier transporter; tumour immunotherapy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Humans
  • Immunotherapy*
  • Killer Cells, Natural
  • Membrane Transport Proteins / metabolism
  • Neoplasms* / metabolism
  • T-Lymphocytes / metabolism

Substances

  • Membrane Transport Proteins